Saubio.com

PLYMOUTH MEETING, Pa. and GERMANTOWN, Md. and HILDEN, Germany, Feb. 24, 2021 /PRNewswire/ — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS)Continue Reading

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS) technology to complement INOVIO’s therapies. (*Complementary when referring to the US regulatory pathway.)Continue Reading

SHENZHEN, China, Feb. 24, 2021 /PRNewswire/ — ZTE Corporation (0763.HK / 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, today announced at MWC Shanghai, the release of i5GC (industry 5GC) network solution oriented to private 5G networks for industry. The solution introduces 5G capabilitiesContinue Reading

OSLO, Norway, Feb. 23, 2021 /PRNewswire/ — Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces 21-month follow-up data from the randomized phase I/II trial of ONCOS-102 in combination with standard of care chemotherapy in malignant pleural mesothelioma (MPM). The trialContinue Reading

New class works solely through nitric oxide (NO)-mediated activity Equivalent intraocular pressure (IOP) lowering and faster onset of activity demonstrated vs. the prostaglandin analog (PGA) travoprost February 23, 2021 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announcedContinue Reading

BANGKOK, Feb. 22, 2021 /PRNewswire/ — Mr. Don Pramudwinai, Deputy Prime Minister and Minister of Foreign Affairs of the Kingdom of Thailand, and a career diplomat, discussed his vision of the role of diplomacy in Post-Covid 19 sustainability in this opinion piece first published on 19 Feb 2021 in the BangkokContinue Reading

Montrouge, France, February 22, 2021 DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the appointment of Michele F. Robertson as its Chief Legal Officer, effective immediately. An experiencedContinue Reading

HONG KONG, Feb. 22, 2021 /PRNewswire/ — As enterprises transition to digital remote-enabled work modes in the new normal, only 50% of the decision makers* are incorporating cybersecurity into their strategies – yet the alarming rise in recent cyberattacks is a threat no one can afford to ignore. By marrying best-in-classContinue Reading

BARCELONA, Spain, Feb. 22, 2021 /PRNewswire/ — The company delivered on its latest guidance despite a challenging year impacted by COVID-19 and the genericization of Aczone®: Net Sales €807.4 MM (-5.4%, flat excluding the Aczone® generic impact), Total Revenues €814.5 MM (-10.3%), EBITDA €238.3MM (-21.7%), all year-on-year and due to theContinue Reading